0
Business
This Drug Stock Has Crushed the S&P 500 Over the Last Decade
April 18, 2026
Scroll
Posted 3 hours ago by
Eli Lilly is leading the GLP-1 charge, but investors have already priced much of the good news into the stock.
The Motley Fool
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.